Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot multicenter study of intermittent antiretroviral therapy in treatment-naive adults with HIV-1 and high CD4 counts
2008-004885-24Phase 2Active
- Sponsor
- ANRS
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atazanavir, ritonavir, abacavir + lamivudine and emtricitabine + tenofovir disoproxil in Human immunodeficiency virus infection type 1, sponsored by ANRS. Primary endpoint: Immunologic stability at months 21 and 24. Started Sep 2008; status: active.
02
Drugs
atazanavirritonavirabacavir + lamivudineemtricitabine + tenofovir disoproxil
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2008-004885-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004885-24.